Health, Dynamic microsimulation

Research articles · Dec 31, 2021

A Dynamic Microsimulation Model for Ageing and Health in England: The English Future Elderly Model

Luke Archer, Nik Lomax, Bryan Tysinger

The University of Leeds, Leeds, UK; University of Southern California, Los Angeles, USA

Volume 14(3) Winter 2021

Cite as: L. Archer, N. Lomax, B. Tysinger; 2021; A Dynamic Microsimulation Model for Ageing and Health in England: The English Future Elderly Model; International Journal of Microsimulation; 14(3); 2–26. doi: 10.34196/ijm.00239

Abstract

Population ageing has the potential to disrupt every aspect of society, placing a great deal of stress in particular on our healthcare and welfare systems. To overcome these challenges will require effective policy interventions with effects that may not be truly seen for decades. Policy makers would therefore benefit from a tool that allows them to assess the long-term impact of their decisions on population health. We have developed such a tool by adapting the well-established Future Elderly Model (FEM) developed in the US to use the English Longitudinal Study of Ageing. The FEM is a Markov microsimulation model for people aged over 50 that generates input populations and transition probabilities using the English Longitudinal Study of Ageing, and can then project the population forward in time assessing the prevalence and incidence of a number of chronic diseases and related economic outputs. By modifying the input populations or transition probabilities, we can use the model to investigate counterfactual scenarios and assess the long-term effects of policy interventions on elderly health. In this paper we describe the model and its workings, provide evidence to validate its outputs, and outline possible applications.

This article contains 10 figures and 14 tables.

Figures

Figure 1. Structure of the FEM simulation.
Figure 2. Handover plots for Chronic diseases by sex.
Figure 3. ROC curves for key binary response variables with a 10-year simulation horizon, from 2002 - 2012.
Figure 4. Chronic Disease prevalence comparisons by age group between FEM and AgeUK almanac of chronic disease in 2014. AgeUK figures include 95% confidence intervals.
Figure 5. Smoking prevalence comparison by age group in 2018. Simulated data (starting in 2012) compared with prevalence statistics generated by the Action on Smoking and Health charity.
Figure 6. Average age at death comparison between baseline and no heart disease intervention. The shaded bands represent Monte Carlo confidence intervals.
Figure 7. Whole population (including smokers and non-smokers) survival curve compared between the baseline and no smoking scenarios.
Figure 8. Whole population prevalence of lung disease comparison between the baseline and no smoking scenarios, with Monte Carlo confidence intervals.
Figure A1. Handover plots for ADLs and IADLs.
Figure A2. Receiver Operating Characteristic curves.

Tables

Table 1. Variables tracked by the model
Domain Variable
Health Mortality, Alzheimers, Cancer, Dementia, Diabetes, Heart Disease, High Cholesterol, Hypertension, Lung Disease, Stroke
Risk Factors BMI, Smoking Status, Alcohol Consumption, Exercise
Functional Limitations Difficulties in Activities of Daily Living (ADLs), and Instrumental Activities of Daily Living (IADLs)
Economic Employed, Unemployed, Retired/Disabled
Table 2. Sample attrition in the over 50s in ELSA. The sample was replenished in 2006, 2008, 2012, and 2014
Year Sample Size
2002 11391
2004 8780
2006 8655
2008 9805
2010 8988
2012 9068
2014 8152
2016 7133
Table 3. Summary statistics on key E-FEM populations.
Characteristics Stock Replenishing Transition
Year 2012 2012 2004 - 2016
Wave 6 6 2 - 8
Age, Mean (SD) 66.2 (10.8) 51.5 (0.5) 66.1 (10.4)
Female % 52.9 49.7 53.0
BMI, Mean (SD) 28.4 (5.4) 27.8 (5.4) 28.3 (5.3)
BMI Category (%)
< 25 28.3 37.1 28.0
≥ 25 & < 30 38.8 34.8 39.9
≥ 30 33.0 28.1 32.1
Smoking Status %
Ever Smoked 62.3 44.5 62.3
Current Smoker 13.6 13.7 14.3
Education Level %
Less than Secondary 29.7 11.1 33.1
Upper Secondary and Vocational 59.9 64.1 65.7
Tertiary 10.4 24.8 11.2
Disease Prevalence % (Incidence)
Cancer 9.8 2.9 9.0 (1.46)
Diabetes 11.1 2.8 10.4 (1.34)
Heart Disease 18.9 7.7 18.7 (2.57)
Stroke 4.7 0.0 4.7 (0.85)
Lung Disease 6.1 0.3 6.2 (0.87)
Hypertension 41.8 20.4 42.0 (3.08)
Alzheimer’s 0.35 0.0 0.32 (0.21)
Dementia 1.25 0.27 1.12 (0.58)
High Cholesterol 37.0 14.9 32.5 (3.92)
Table 4. Information on transitioned variables in the model.
Outcome Variable Type Regression Model Predictors*
Health Status Risk Behaviours Economic Predictors Demographics
Mortality incidence Binary Absorbing Probit Cancer
Diabetes
Heart Disease
Lung Disease
Stroke
Dementia
Smoking Age
Sex
Education
Cancer incidence Binary Absorbing Probit BMI
Smoking
Alcohol Consumption
Age
Sex
Ethnicity
Education
Diabetes incidence Binary Absorbing Probit Hypertension
High Cholesterol
BMI
Physical Activity
Alcohol Consumption
Age
Sex
Ethnicity
Education
Heart Disease incidence Binary Absorbing Probit Diabetes
Hypertension
High Cholesterol
BMI
Smoking
Physical Activity
Alcohol Consumption
Age
Sex
Ethnicity
Education
Hypertension incidence Binary Absorbing Probit High Cholesterol BMI
Smoking
Alcohol Consumption
Physical Activity
Age
Sex
Ethnicity
Education
Lung Disease incidence Binary Absorbing Probit BMI
Smoking
Age
Sex
Ethnicity
Education
Stroke incidence Binary Absorbing Probit Hypertension
Diabetes
High Cholesterol
BMI
Smoking
Alcohol Consumption
Age
Sex
Ethnicity
Education
High Cholesterol incidence Binary Absorbing Probit BMI
Smoking
Physical Activity
Age
Sex
Ethnicity
Education
Dementia incidence Binary Absorbing Probit Hypertension
Stroke
BMI
Smoking
Age
Sex
Ethnicity
Education
Alzheimers incidence Binary Absorbing Probit Hypertension
Stroke
BMI
Smoking
Alcohol Consumption
Age
Sex
Ethnicity
Education
Start/Stop Smoking Binary Probit BMI Age
Sex
Ethnicity
Education
Alcohol Consumption Binary Probit BMI
Physical Activity
Age
Sex
Ethnicity
Education
BMI Continuous OLS BMI
Physical Activity
Age
Sex
Ethnicity
Education
Functional Limitations Ordered Oprobit Stroke
Dementia
Alzheimers
BMI
Smoking
Age
Sex
Ethnicity
Education
Physical Activity Ordered Oprobit Functional Limitations
Physical Activity
Age
Sex
Ethnicity
Education
Labour Force Participation Unordered Mlogit Functional Limitations Age
Sex
Ethnicity
Education

All predictor variables are 2 year lag.

Table 5. Parameter estimates for probit model of heart disease incidence.
Heart Disease
Male 0.108***
White -0.0729
Less than Secondary Education -0.0642
Higher or further education 0.0194
Lag of age spline, less than 65 0.0103
Lag of age spline, 65 to 74 0.0262***
Lag of age spline, more than 75 0.0182***
Lag of BMI spline, less than 30 0.163
Lag of BMI spline, more than 30 0.218
Lag of ever smoker 0.0259
Lag of current smoker 0.0264
Lag of heavy smoker (>20 cigs/day) 0.0836
Lag of problem drinker (>12 drinks/week) -0.0318
Lag of doctor ever - Diabetes 0.0520
Lag of doctor ever - Hypertension 0.163***
Lag of doctor ever - High Cholesterol 0.0659*
Lag of activity level - Low 0.174**
Lag of activity level - Moderate 0.0979*
Constant -3.172***
N 22,333
Pseudo R2 0.0335
Table 6. Parameter estimates for probit models of smoking initiation and cessation.
Smoking
Started Stopped
Male 0.112** 0.0263
White 0.0228 0.257
Less than Secondary education 0.188*** -0.106*
Higher or Further education -0.154** 0.215**
Lag of age spline, less than 65 -0.00572 0.0188***
Lag of age spline, 65 to 74 -0.0186** -0.00979
Lag of age spline, more than 75 -0.0289** 0.0171
Lag of BMI spline, less than 30 -0.414* 0.839***
Lag of BMI spline, more than 30 0.25 0.0703
Constant -0.649 -5.060***
N 41951 6157
Pseudo R2 0.019 0.0129
Table 7. Life year and disability-free life year comparison between baseline and no smoking scenario. This is a treatment on the treated analysis, so only including respondents that smoke.
Scenario Life Years Disability-free Life Years
Baseline 24.4 16.9
Intervention 31.4 21.4
Table 8. Average improvement in life years and disability-free life years between scenarios by highest level of education.
Education Level Life Years Improvement Disability-free Life Years Improvement
1 5.5 3.4
2 8.4 5.3
3 7.7 5.4
Table A1. Summary statistics for raw and imputed stock populations, including the percentage of missing data where applicable.
Characteristics Raw Stock Imputed Missing (%)
Age, Mean (SD) 66.5 (10.8) 66.2 (10.8) 0
Female (%) 52.9 52.9 0
BMI, Mean (SD) 28.4 (5.4) 28.4 (5.4) 19.2
BMI Category (%)
< 25 28.3 28.3 -
≥ 25 & < 30 42.2 42.2 -
≥ 30 29.5 29.5 -
Smoking Status (%)
Ever Smoked 62.5 62.3 1.83
Current Smoker 12.2 13.6 0.05
Education Level (%) 20.9
Less than Secondary 38.6 38.6 -
Upper Secondary and Vocational 48.0 47.9 -
Some University or more 13.5 13.5 -
Initial Disease Prevalence (%)
Cancer 9.8 9.8 0.009
Diabetes 11.1 11.1 0.009
Heart Disease 18.9 18.9 0.009
Table A2. Raw vs imputed BMI mean and standard deviation at each wave of ELSA.
Wave Raw BMI Imputed BMI
1 - 28.0 (5.3)
2 28.0 (4.9) 28.0 (5.0)
3 - 28.2 (5.2)
4 28.3 (5.4) 28.4 (5.4)
5 - 28.4 (5.4)
6 28.4 (5.3) 28.4 (5.4)
7 - 28.4 (5.4)
8 28.3 (5.5) 28.3 (5.5)
Table A3. T-test results for health outcomes.
Variable FEM 3 ELSA 3 P value 3 FEM 5 ELSA 5 P value 5 FEM 8 ELSA 8 P value 8
Alzheimers 0.0067 0.00325 0.00076 0.0103 0.00404 0 0.0178 0.0119 0.0204
Any ADLs 0.184 0.213 0 0.199 0.234 0 0.241 0.225 0.0938
Any IADLs 0.204 0.222 0.012 0.230 0.255 0.00292 0.268 0.266 0.839
Cancer 0.1 0.0863 0.00448 0.130 0.119 0.0836 0.176 0.164 0.182
Dementia 0.0159 0.0102 0.00156 0.0226 0.0194 0.24 0.0324 0.164 0.0214
Diabetes 0.109 0.0937 0.00275 0.132 0.128 0.571 0.164 0.151 0.125
Heart disease 0.220 0.175 0 0.26 0.222 0 0.328 0.29 0.00031
Hypertension 0.453 0.448 0.555 0.491 0.506 0.115 0.549 0.538 0.381
Lung disease 0.0836 0.0719 0.00989 0.0957 0.0863 0.0857 0.111 0.0898 0.00167
Stroke 0.0558 0.0504 0.156 0.0667 0.06743 0.875 0.082 0.089 0.289
Table A3. t-test results for economic outcomes.
Variable FEM 3 ELSA 3 P value 3 FEM 5 ELSA 5 P value 5 FEM 8 ELSA 8 P value 8
Employed 0.284 0.285 0.906 0.194 0.179 0.0412 0.0809 0.0842 0.606
Unemployed 0.00102 0.00662 0.0132 0.00519 0.00675 0.321 0.00137 0.00092 0.529
Retired/Disabled 0.706 0.707 0.0.84 0.801 0.811 0.167 0.918 0.912 0.411
Table A3. t-test results for risk behaviours.
Variable FEM 3 ELSA 3 P value 3 FEM 5 ELSA 5 P value 5 FEM 8 ELSA 8 P value 8
BMI* 28.4 28.0 0.0014
Drinks Alcohol 0.866 0.874 0.205 0.859 0.851 0.239 0.844 0.839 0.552
Problem Drinker 0.12 0 0 0.122 0.127 0.487 0.109 0.113 0.567
Activity - Low 0.0907 0.101 0.0426 0.099 0.13 0 0.112 0.129 0.0304
Activity - Moderate 0.164 0.162 0.739 0.168 0.181 0.0775 0.183 0.201 0.0508
Activity - High 0.745 0.736 0.231 0.733 0.689 0 0.706 0.669 0.00097
Smoke Now 0.132 0.143 0.0678 0.106 0.116 0.106 0.076 0.0708 0.391
Smoke Ever 0.637 0.628 0.279 0.639 0.648 0.322 0.638 0.658 0.0646
Heavy Smoker 0.0234 0.0297 0.906 0.0214 0.0229 0.595 0.0128 0.0136 0.761

ELSA only reports BMI information for even waves.

Table A3. t-test results for mortality.
Variable FEM 3 ELSA 3 P value 3 FEM 5 ELSA 5 P value 5 FEM 8 ELSA 8* P value 8
Died 0.0294 0.0412 0.00033 0.0435 0.0602 0 0.0596 0 0

End of life interviews are only reporte for waves 2-6 (excluding wave 5). There is therefore no mortality informationfor waves 7 or 8.